Literature DB >> 16674918

Influence of dendrimer's structure on its activity against amyloid fibril formation.

B Klajnert1, M Cortijo-Arellano, J Cladera, M Bryszewska.   

Abstract

Inhibition of fibril assembly is a potential therapeutic strategy in neurodegenerative disorders such as prion and Alzheimer's diseases. Highly branched, globular polymers-dendrimers-are novel promising inhibitors of fibril formation. In this study, the effect of polyamidoamine (PAMAM) dendrimers (generations 3rd, 4th, and 5th) on amyloid aggregation of the prion peptide PrP 185-208 and the Alzheimer's peptide Abeta 1-28 was examined. Amyloid fibrils were produced in vitro and their formation was monitored using the dye thioflavin T (ThT). Fluorescence studies were complemented with electron microscopy. The results show that the higher the dendrimer generation, the larger the degree of inhibition of the amyloid aggregation process and the more effective are dendrimers in disrupting the already existing fibrils. A hypothesis on dendrimer-peptide interaction mechanism is presented based on the dendrimers' molecular structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674918     DOI: 10.1016/j.bbrc.2006.04.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay.

Authors:  Yi-Jiong Zhang; Jing-Ming Shi; Cai-Juan Bai; Han Wang; Hai-Yun Li; Yi Wu; Shang-Rong Ji
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

2.  Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation.

Authors:  Celia Cabaleiro-Lago; Fiona Quinlan-Pluck; Iseult Lynch; Kenneth A Dawson; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2010-01-27       Impact factor: 4.418

Review 3.  Complex polyamines: unique prion disaggregating compounds.

Authors:  Surachai Supattapone; Justin R Piro; Judy R Rees
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

4.  Nanomedicine for prion disease treatment: new insights into the role of dendrimers.

Authors:  James M McCarthy; Dietmar Appelhans; Jörg Tatzelt; Mark S Rogers
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

5.  Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.

Authors:  Morteza Mahmoudi; Fiona Quinlan-Pluck; Marco P Monopoli; Sara Sheibani; Hojatollah Vali; Kenneth A Dawson; Iseult Lynch
Journal:  ACS Chem Neurosci       Date:  2013-01-23       Impact factor: 4.418

Review 6.  Nanoparticles in relation to peptide and protein aggregation.

Authors:  Masihuz Zaman; Ejaz Ahmad; Atiyatul Qadeer; Gulam Rabbani; Rizwan Hasan Khan
Journal:  Int J Nanomedicine       Date:  2014-02-12

7.  Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers.

Authors:  Annarita Falanga; Rossella Tarallo; Thomas Carberry; Massimiliano Galdiero; Marcus Weck; Stefania Galdiero
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

Review 8.  New Advances in General Biomedical Applications of PAMAM Dendrimers.

Authors:  Renan Vinicius de Araújo; Soraya da Silva Santos; Elizabeth Igne Ferreira; Jeanine Giarolla
Journal:  Molecules       Date:  2018-11-02       Impact factor: 4.411

9.  Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).

Authors:  James M McCarthy; Markus Franke; Ulrike K Resenberger; Sibeal Waldron; Jeremy C Simpson; Jörg Tatzelt; Dietmar Appelhans; Mark S Rogers
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

Review 10.  Neuronal death in Alzheimer's disease and therapeutic opportunities.

Authors:  Rossen Donev; Martin Kolev; Bruno Millet; Johannes Thome
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.